Genmab AS (GMAB)
21.32
-0.34
(-1.59%)
USD |
NASDAQ |
Nov 14, 13:10
Genmab 1 Year Total Returns (Daily): -32.60% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | -32.60% |
November 12, 2024 | -28.55% |
November 11, 2024 | -26.23% |
November 08, 2024 | -25.55% |
November 07, 2024 | -21.71% |
November 06, 2024 | -22.60% |
November 05, 2024 | -21.79% |
November 04, 2024 | -21.69% |
November 01, 2024 | -22.07% |
October 31, 2024 | -21.41% |
October 30, 2024 | -20.02% |
October 29, 2024 | -18.65% |
October 28, 2024 | -18.58% |
October 25, 2024 | -20.41% |
October 24, 2024 | -22.70% |
October 23, 2024 | -23.21% |
October 22, 2024 | -23.69% |
October 21, 2024 | -23.66% |
October 18, 2024 | -21.78% |
October 17, 2024 | -28.07% |
October 16, 2024 | -30.57% |
October 15, 2024 | -28.19% |
October 14, 2024 | -26.70% |
October 11, 2024 | -33.30% |
October 10, 2024 | -33.10% |
Date | Value |
---|---|
October 09, 2024 | -32.25% |
October 08, 2024 | -32.93% |
October 07, 2024 | -33.38% |
October 04, 2024 | -31.99% |
October 03, 2024 | -31.42% |
October 02, 2024 | -30.81% |
October 01, 2024 | -31.53% |
September 30, 2024 | -30.88% |
September 27, 2024 | -31.56% |
September 26, 2024 | -33.97% |
September 25, 2024 | -34.27% |
September 24, 2024 | -33.45% |
September 23, 2024 | -33.09% |
September 20, 2024 | -31.79% |
September 19, 2024 | -29.12% |
September 18, 2024 | -29.93% |
September 17, 2024 | -30.41% |
September 16, 2024 | -30.02% |
September 13, 2024 | -25.92% |
September 12, 2024 | -28.29% |
September 11, 2024 | -28.21% |
September 10, 2024 | -27.23% |
September 09, 2024 | -27.34% |
September 06, 2024 | -26.48% |
September 05, 2024 | -27.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-39.80%
Minimum
Jun 16 2022
101.5%
Maximum
Jul 22 2020
15.39%
Average
11.80%
Median
1 Year Total Returns (Daily) Benchmarks
Novo Nordisk AS | 7.26% |
Ascendis Pharma AS | 40.93% |
Galecto Inc | -52.07% |
Evaxion Biotech AS | -75.03% |
IO Biotech Inc | 2.08% |